RxDoctor Payments DataLook up a doctor →

Saundra Maass-Robinson

Psychiatry · Atlanta, GANPI 1154442598

Payments from drug & device makers

$11,087,772in general payments, 2019–2025

Across 1,565 payments — averaging $7084.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3.1M
  • E.r. Squibb & Sons, L.L.C.$2.3M
  • Teva Pharmaceuticals USA, Inc.$1.9M
  • Sumitomo Pharma America, Inc.$973K
  • Sunovion Pharmaceuticals Inc.$917K
  • Boehringer Ingelheim International GmbH$408K
  • plus $1.5M from 14 others

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)980$3,137,882
E.r. Squibb & Sons, L.L.C.10$2,313,400
Teva Pharmaceuticals USA, Inc.115$1,866,285
Sumitomo Pharma America, Inc.91$972,697
Sunovion Pharmaceuticals Inc.86$916,754
Boehringer Ingelheim International GmbH123$407,571
Supernus Pharmaceuticals, Inc.26$362,994
Sage Therapeutics, LLC30$296,751
Boehringer Ingelheim8$292,752
Otsuka Pharmaceutical Development & Commercialization, Inc.10$231,372
Janssen Research & Development, LLC18$151,585
Merck11$55,537
AbbVie(2 entities)19$33,336
Biogen3$30,262
Avanir Pharmaceuticals, Inc.1$12,751
Bioxcel Therapeutics, Inc.3$5,250
Lundbeck LLC26$406
Otsuka America Pharmaceutical, Inc.1$106
Bausch Health US, LLC3$55
Takeda Pharmaceuticals U.S.A., Inc.1$26

How this compares

$11,087,772 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia →

Other psychiatry in Atlanta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →